CN1113760A - Compound phosphoric acid solution for treating cystic tumor and hemangioma - Google Patents
Compound phosphoric acid solution for treating cystic tumor and hemangioma Download PDFInfo
- Publication number
- CN1113760A CN1113760A CN 94114274 CN94114274A CN1113760A CN 1113760 A CN1113760 A CN 1113760A CN 94114274 CN94114274 CN 94114274 CN 94114274 A CN94114274 A CN 94114274A CN 1113760 A CN1113760 A CN 1113760A
- Authority
- CN
- China
- Prior art keywords
- phosphoric acid
- liquid
- hemangioma
- cystic tumor
- compound recipe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 229910000147 aluminium phosphate Inorganic materials 0.000 title claims abstract description 25
- 150000001875 compounds Chemical class 0.000 title claims abstract description 20
- 208000012106 cystic neoplasm Diseases 0.000 title claims abstract description 17
- 201000011066 hemangioma Diseases 0.000 title abstract description 10
- 239000007788 liquid Substances 0.000 claims description 45
- 238000011282 treatment Methods 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 5
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000002075 main ingredient Substances 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 8
- 239000007924 injection Substances 0.000 abstract description 7
- 238000002347 injection Methods 0.000 abstract description 7
- 230000003796 beauty Effects 0.000 abstract description 4
- 210000005081 epithelial layer Anatomy 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 206010011732 Cyst Diseases 0.000 description 12
- 208000031513 cyst Diseases 0.000 description 12
- 239000002775 capsule Substances 0.000 description 6
- 238000011010 flushing procedure Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 210000001847 jaw Anatomy 0.000 description 4
- 210000004373 mandible Anatomy 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 210000000589 cicatrix Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- GRIXGZQULWMCLU-UHFFFAOYSA-L disodium;7-[[2-carboxylato-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].[Na+].C12OCC(CSC=3N(N=NN=3)C)=C(C([O-])=O)N2C(=O)C1(OC)NC(=O)C(C([O-])=O)C1=CC=C(O)C=C1 GRIXGZQULWMCLU-UHFFFAOYSA-L 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 229960005491 sodium morrhuate Drugs 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010016717 Fistula Diseases 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000009146 rhinoscleroma Diseases 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000017234 Bone cyst Diseases 0.000 description 1
- 206010006164 Branchial cyst Diseases 0.000 description 1
- 208000000529 Branchioma Diseases 0.000 description 1
- 208000003163 Cavernous Hemangioma Diseases 0.000 description 1
- -1 Compound phosphate Chemical class 0.000 description 1
- 208000010383 Dentigerous Cyst Diseases 0.000 description 1
- 208000001154 Dermoid Cyst Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 208000002595 Radicular cyst Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 231100000429 cutaneous necrosis Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000001460 masseteric effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010063413 odontogenic cyst Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 208000028528 solitary bone cyst Diseases 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides the compound phosphoric acid solution for treating the cystic tumor and the hemangioma, which is free from operation, convenient, economical and high in curative effect. Uses phosphoric acid as main component, and adopts injection method to destroy epithelial layer cells of cystic tumor and hemangioma, so as to achieve the purpose of curing. The invention has the advantages of no operation, simple operation, no side effect, no complication, economy and practicality, and is beneficial to beauty.
Description
The present invention relates to a kind of treatment cystic tumor and angiomatous compound recipe phosphoric acid liquid.
Cystic tumor and hemangioma are a kind of commonly encountered diseases, frequently-occurring disease.Treatment cystic tumor and angiomatous radical cure method are surgical removal at present, and the operation meeting causes suffering and fear to patient, and part the old,weak,sick and disabled person can not accept surgical operation, the operative therapy wound is big simultaneously, and is dangerous big, and complication easily takes place, can destroy the normal surrounding tissue structure, influence normal physiological function, leave over cicatrix, cause deformity, the influence beauty treatment, the expense height, working strength is big, also needs certain technical merit.
Treatment cystic tumor and angiomatous other method are as described below at present:
One, the treatment mucous cyst has: 1, adopt the trichloroacetic acid injection treatment, effect is undesirable, and is not easy to operate, and the bad reflection of postoperative is obvious, seldom uses.2, adopt 30% sodium chloride, iodine tincture, 5% sodium morrhuate, prednisone is outstanding, and injection treatments such as tetracycline, one time cure rate are not high, effect is undesirable, sodium morrhuate postoperative obvious 3, freezing, the laser therapy of reflection that swells and ache, and this method is together destroyed cyst top layer skin or mucosa, tissue injury's area is big, leave over cicatrix, pigmentation, influence beauty treatment, and instrument and equipment is expensive complicated, generally can not popularize.
Two, the angiomatous method of treatment has: 1, laser, and freezing, Therapeutic Method such as sodium morrhuate.2, X-ray therapy, isotope sticks, and cure rate is not high, and toxicity is big, easily causes radiological hazard.
Three, the irrigation of employing treatment mandibular bone cyst is arranged abroad, this method needs regularly flushing repeatedly, treats that blister cavities dwindles back reuse surgical removal.
Though above method has certain curative effect, but subject range is little, can not be used for the treatment of various types of cystic tumors and hemangioma, I am under the inspiration of said method, at first analyze various types of cystic tumors and angiomatous organizational structure and pathology growth course thereof, found out its general character, set about seeking a kind of no side effects again, economy is easily got, and adopts injecting method can both reach the new medicinal liquid of curing purpose to various cystic tumors and hemangioma.
The cystic tumor skin is the fibroid cyst wall, liner thin layer epithelial cell, and intracavity is full of transparent or weak yellow liquid.Capsule liquid is excretory by epithelial cell, and epithelial layer is separated blister cavities and mesoderm, stops mass exchange between the two, except part water and salt, liquid can not be absorbed fully, and liquid constantly gathers, and forms a kind of normal pressure, blister cavities is enlarged gradually, as long as destroy cyst liner epithelial layer, intracavity liquid can not gather and be absorbed, granulation tissue hyperplasia, be full of blister cavities, can cure.Hemangioma is made up of the thin-walled blood vessel of many liner endotheliums, belongs to the multilocular cyst that intracavity is full of blood.
The purpose of this invention is to provide a kind of treatment cystic tumor that need not perform the operation, have no side effect and angiomatous compound recipe phosphoric acid liquid.
Its technical solution is:
Phosphoric acid is the main component of this medicinal liquid, and main effect is to destroy the epithelial layer cell, makes it coagulation necrosis; A spot of hydrochloric acid, effect are the permeabilitys that strengthens this medicinal liquid; An amount of sodium dihydrogen phosphate plays cushioning effect.
With preparation 100ml compound recipe phosphoric acid liquid is example, gets phosphatase 24 5ml, hydrochloric acid 5ml, sodium dihydrogen phosphate 2g, distilled water 50ml makes the medicinal liquid of mix homogeneously, and constituent of the present invention: phosphoric acid is 45%, hydrochloric acid is 5%, the every 100ml medicinal liquid of sodium dihydrogen phosphate 2g(), distilled water 50%, phosphoric acid are one of main components in the human body, compound recipe phosphoric acid liquid acidity is suitable, be easy to control and operation, no side effects can not cause skin and mucosa injury, and self limiting is arranged, can not cause the deep tissue necrosis, and medicinal liquid injection intracavity, act on after 2-4 minute and extracting out, medicine does not retain in vivo, is not absorbed by health.
The application process of compound recipe phosphoric acid liquid is simple and easy, after the local anesthesia, and the blister cavities puncture, capsule liquid is pumped, inject the compound recipe phosphoric acid liquid, injection rate should make blister cavities full, so that cyst wall is all acted on, stay medicine 2-4 minute, medicine is extracted out, and reuse aquesterilisa flushing blister cavities 3-4 time is extracted flushing liquor out at last, syringe needle is extracted, do not made overflow of drug fluid.
Compound recipe phosphoric acid liquid treatment cystic tumor and angiomatous evident in efficacy, since 92 years, I adopt self-control compound recipe phosphoric acid liquid is patient treatment, through clinical observation, has obtained good effect, sees the following form:
| The example number | Once cure | Secondary is cured | Invalid | Effective percentage % | Recurrence | Relapse rate % | |
| Mucous cyst | 78 | 75 | 3 | 0 | 100 | 3 | 3.8 |
| Sublingual ptyalocele | 9 | 9 | 0 | 0 | 100 | 0 | 0 |
| Hemangioma | 10 | 10 | 0 | 0 | 100 | 0 | 0 |
| The neck soft cyst | 18 | 15 | 2 | 1 | 94.4 | 0 | 0 |
| Cyst of jaw | 22 | 18 | 3 | 1 | 95.4 | 0 | 0 |
| Add up to | 137 | 127 | 8 | 2 | 98.5 | 3 | 2.2 |
Annotate: 1,2 routine nonresponders are respectively dentigerous cyst and dermoid cyst, are difficult for absorbed material because of intracavity contains.
2, mucous cyst has three example recurrences, but from histological angle analysis, does not belong to recurrence, but regeneration.
With compound recipe phosphoric acid liquid treatment cystic tumor and hemangioma,, have its unique advantage through my clinical practice: 1, replaced traditional surgical removal method with injection, the cure rate height, degree of safety is big.2, be applicable to various types of cystic tumors of treatment and hemangioma.3, sequela can not take place, as scar contracture deformity, bone monstrum deficiens etc.4, to all available this method treatments such as not fitting into operating patient such as anemia, suffer from systemic disease, be old, the clinical examination vital sign is stable.5, eliminated patient's fear, easily accepted, the treatment no significant discomfort sense in back by the patient.6, surrounding tissue organ pipe not damaged is destroyed, do not influence normal physiological function; Do not leave over cicatrix, do not influence beauty treatment.7, be different from surgical operation needs certain convalescent periods, do not have complication such as shock, hemorrhage, fracture, can recover orthobiosis after the operation.8, economical, simple and easy, be convenient to promote, but cost saving is more than 90%.
Introduce several parts of typical case histories below with the treatment of compound recipe phosphoric acid liquid:
Example one:
Lee * *, the woman, 25 years old, the workman, on May 3rd, 92 went to a doctor.The swollen thing of the living painless property of lower-left lip is surplus January, and the labiad outer process has foreign body sensation, does not seek and obvious inducement.The cryptomere sense of touching.It is big to give birth to rice, does not have and touches a tender spot, and mucosa does not have redness.Examine and be mucous cyst.The thickness colourless liquid is extracted in puncture out.Inject compound recipe phosphoric acid liquid 0.2ml, 2 minutes afterflush.The postoperative lip does not have swelling, is beans shape scleroma piece after 1 week, and 3 weeks were grain of rice shape, and check scleroma piece disappears after January.
Example two:
Lee * *, the woman 6 years old, goes to a doctor on March 28th, 93.The swollen thing of the painless property in right Sublingual is surplus half a year.Looking into a right mouthful of end has the about 2x1cm projection thing that swell, the capsule sexuality, and mucosa does not have redness, and jaw downcomer mouth is secreted normally.B ultrasonic shows the cystic lesion of 1.9x2.3cm, and two rooms are coagulated in the bosom.Anterior radiography is 1.2x1.0cm resistance light district.The about 1.2ml weak yellow liquid of anterior extraction, the more viscous pale liquid of 0.3ml is extracted in the rear portion puncture out, examines to be two rooms sublingual ptyalocele.In the blister cavities of front and back, inject 0.5ml and 0.2ml compound recipe phosphoric acid liquid respectively, flushing in 2 minutes.Mouth end mild swelling 3 days is followed up a case by regular visits to and was not had recurrence in 1 year.
Example three:
Zhao * *, the woman, 23 years old, the peasant, on January 11st, 92 went to a doctor.The painless property of right cervical region lump 1 year is surplus, grows up gradually.Lay one's hand on and the soft lump of 5x5cm the right angle of mandible back lower place, fluctuation, and the oncontacting tenderness, B ultrasonic shows the cystic lesion of 5.2x3.8cm, the border is clear; 36ml pale liquid is extracted in puncture out.Examine and be branchial cyst.Extract capsule liquid out, inject compound recipe phosphoric acid liquid 6ml, push the part, so that the medicinal liquid stepless action is in cyst wall, and 3 minutes afterflush, pressure dressing.Local mild swelling 4 days does not have obviously pain.Because of pressure dressing can not be eliminated dead space fully, about 10ml kermesinus liquid is extracted in the back puncture of 1 week out.January, liquid was not extracted in check out, and B ultrasonic shows no cystic lesion, followed up a case by regular visits to and did not have recurrence in 2 years.
Example four:
Yin * *, the man, 51 years old, the peasant went to a doctor on October 28th, 91.The swollen thing of Upper Anterior Teeth lip side is suppurated half a year more than a year, and it is month surplus to swell and ache, and it is many to suppurate, and 1 complexion changed is black, the lip side thing 2x2cm that swell, and the table tennis sense, the about 5ml of suppurative liquid is extracted in puncture out, and X-ray film shows palate front portion 2x2.5cm transparent area, sharpness of border.Examine and be radicular cyst, the puncture flushing is behind the no purulence thing, injected compound recipe phosphoric acid liquid 4ml November 12, extract the flushing of compound recipe phosphoric acid liquid after 4 minutes out, because of fistula is arranged, blister cavities is open, put iodine spinning 3 weeks of bar, remove gradually, 5 weeks back check fistula disappears, and liquid is not extracted in puncture out, after 2 years, the X sheet shows no capsule sample diseased region.
Example five:
With * *, the woman, 23 years old, the teacher, on February 24th, 92 went to a doctor.Year surplus the swollen thing 10 of the painless property of right angle of mandible, grow up gradually, influence face.Swollen thing is positioned at the right angle of mandible outside, the masseteric muscle leading edge, and matter is soft, about 3x4cm, can not disappearing of pressure, 2ml blood is extracted in puncture out, and swollen thing diminishes, and multiple enlargement again is full after 1 minute, B ultrasonic shows the fluidity occupy-place of 2x2cm, and the border is more clear, examines to be cavernous hemangioma, injects the about 1.2ml of compound recipe phosphoric acid liquid.Next day check, right angle of mandible and rear, the have an appointment swelling district of 5x5cm of jaw inferior segment, there is the cutaneous necrosis district of 0.3x0.2cm at injection pin hole place because of drug extravasation, and the slight left avertence of right bicker shows that jaw lower edge nerve is because of the swelling pressurized, opening degree and open-type are normal, do not have obviously pain, about 2.5ml weak yellow liquid is extracted in check in 10 days out, and distortion of commissure alleviates, check in 1 month is the 2x1.5cm hard block, 2 months is 1x1cm, and the check hard block disappeared in 2 years, and B ultrasonic shows no capsule sample pathological changes.
Claims (2)
1, a kind of cystic tumor and angiomatous compound recipe phosphoric acid liquid of being used for the treatment of is characterized in that:
A, phosphoric acid are Main Ingredients and Appearance;
B, hydrochloric acid, sodium dihydrogen phosphate are auxiliary composition.
2, compound recipe phosphoric acid liquid according to claim 1 is characterized in that: phosphorus acid content is 45% of a medicinal liquid; Content of hydrochloric acid is 5% of a medicinal liquid; Sodium dihydrogen phosphate is the every 100ml medicinal liquid of 2g(); Distilled water is 50% of a medicinal liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94114274 CN1090942C (en) | 1994-05-20 | 1994-12-28 | Compound phosphoric acid solution for treating cystic tumor and hemangioma |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94110601 | 1994-05-20 | ||
| CN94110601.2 | 1994-05-20 | ||
| CN 94114274 CN1090942C (en) | 1994-05-20 | 1994-12-28 | Compound phosphoric acid solution for treating cystic tumor and hemangioma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1113760A true CN1113760A (en) | 1995-12-27 |
| CN1090942C CN1090942C (en) | 2002-09-18 |
Family
ID=25743452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94114274 Expired - Fee Related CN1090942C (en) | 1994-05-20 | 1994-12-28 | Compound phosphoric acid solution for treating cystic tumor and hemangioma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1090942C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433716B (en) * | 2007-11-14 | 2012-05-30 | 安兵 | Composition for treating malignant solid tumors and preparation thereof and use |
| WO2022068918A1 (en) * | 2020-09-30 | 2022-04-07 | 成都夸常奥普医疗科技有限公司 | Pharmaceutical composition comprising acid-base neutralization combination and application thereof |
-
1994
- 1994-12-28 CN CN 94114274 patent/CN1090942C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433716B (en) * | 2007-11-14 | 2012-05-30 | 安兵 | Composition for treating malignant solid tumors and preparation thereof and use |
| WO2022068918A1 (en) * | 2020-09-30 | 2022-04-07 | 成都夸常奥普医疗科技有限公司 | Pharmaceutical composition comprising acid-base neutralization combination and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1090942C (en) | 2002-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1895600A (en) | Chinese-medicinal suppository for treating lumbar vertebrae disease | |
| CN102228588A (en) | Traditional Chinese medicine composition for external use for treating sciatica, and preparation method thereof | |
| CN1090942C (en) | Compound phosphoric acid solution for treating cystic tumor and hemangioma | |
| EA012294B1 (en) | Medicaments made on the basis of honey, their use and a method for preparation thereof | |
| CN110302228A (en) | A kind of biological agent that treating hemorrhoid and its application | |
| CN113209179A (en) | External washing medicine for hemorrhoids and fistula and preparation method and application method thereof | |
| CN1895633A (en) | Chinese-medicinal suppository for treating cervical spondylosis and its preparation | |
| RU2147883C1 (en) | Method for treating the cases of upper extremity lymphedema | |
| CN109954062A (en) | A kind of activating microcirculation and removing stasis medicinal, swelling and pain relieving exterior-applied medical wine | |
| CN115990232B (en) | Traditional Chinese medicine composition for treating recurrent urinary tract infection and application thereof | |
| RU2811254C1 (en) | Method of treating erythematotelangiectatic subtype of rosacea by points | |
| CN1275623C (en) | Green peach hull and psoralea fruit containing liquor for treating leucoderma and alphos | |
| CN108114090A (en) | A kind of Chinese medicine composition for treating hemorrhoid and burn and scald | |
| CN106794187A (en) | For bone, cartilage, tooth and paradenlal tissue regeneration and the preparation for the treatment of tumour and tumour | |
| RU2692978C1 (en) | Method of prevention of external nose cicatrical deformities in patients with open injuries of the nose bone frame | |
| CN1046634C (en) | Injection for treating angioma and its preparing technology | |
| RU2441609C1 (en) | Method for knee cap lateral fixation | |
| Purohit et al. | MANAGEMENT OF STREE ROGAS WSR TO ROLE OF STHANIK CHIKITSA IN DISEASE PATHOGENESIS | |
| RU2200557C1 (en) | Method for treating hypertrophic and keloid scars | |
| CN1103230C (en) | Nevus eliminating ointment | |
| CN105168632A (en) | Traditional Chinese medicinal plastics for promoting healing of wound of cesarean section and preparation method thereof | |
| Badwe et al. | DIABETIC CARBUNCLE A COMPLICATION OF INTRA-ARTICULAR STEROIDAL INJECTION: A CASE STUDY | |
| Shekokar et al. | A case control study of Tilkalka (Sesamum paste) Madhusarpivarti in the management of Vidradhi Bhedana and Vistravana (i & d) | |
| RU2286162C1 (en) | Method for treating skin manifestations of scleroderma | |
| CN113521158A (en) | A topical Chinese medicinal composition for treating wound ulcer, pyocutaneous disease, trauma and dermatoses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |